Atazanavir/ritonavir regulatory update

FDA granted tentative marketing approval to an NDA from Mylan's Mylan Laboratories Ltd. subsidiary for a fixed-dose atazanavir/ritonavir combination to treat HIV/AIDS infection. The product will be el...